| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $46K | -98.1% |
| SG&A Expense | $69K | -26.0% |
| Operating Income | -$1.9M | +70.7% |
| Net Income | -$1.7M | +73.1% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Inventory | $986 | -6.1% |
| Current Assets | $237K | +85.4% |
| Total Assets | $12.4M | +2.1% |
| Current Liabilities | $2.1M | +77.0% |
| Total Liabilities | $2.3M | +89.9% |
| Stockholders' Equity | $10.1M | -7.6% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.0M | -2444.8% |
| Investing Cash Flow | -$140K | — |
| Financing Cash Flow | $1.2M | — |